A higher antibody-to-antigen ratio enhances activation of immune cells such as phagocytes and natural killer cells, with maximal activation observed when multiple antibodies bind per antigen set.

The agreement grants GC Cell exclusive rights to utilize DAAN Biotherapeutics' antibody sequence in the research and development of CAR-T (chimeric antigen receptor T cell) and CAR-NK (chimeric ...

In antiacetylcholine receptor (AChR) antibody-positive (Ab+ ... while downregulating pathways associated with antigen binding. In addition, eculizumab reduced leukotriene production, possibly due to ...